Elevated levels of IFIT1, IFIT3 and IFIT5 have been shown to play significant roles in cancer progression, while the decreased expression of IFIT2 has been reported to enhance invasion, tumor progression, and drug resistance in various cancer types [25,26,27,28,29,30,31,32]. Here, IFIT2 is linked to neoplasm.